News
Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...
Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...
FDA clearance would allow Medtronic to integrate the device with Abbott's continuous glucose monitoring sensor, advancing the companies' partnership.
Medtronic has received Food and Drug Administration approval for a version of its latest glucose sensor that can pair with the company’s insulin pumps. The device, called Simplera Sync ...
Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...
Parkinson's disease patients in SC take drugs to help ease symptoms but can often be left on a yo-yo of up and down time. A ...
Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...
After just 48 hours of drug exposure, the cells began producing insulin and responding to glucose—just like normal beta cells do. Related Stories Common diabetes drugs may protect against ...
Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results